Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 43 out of 100. Long-term cohort studies

Topic: Risk, prevention and care in population studies

Plain-language summary

Three subtypes emerged: severe obesity-related inflammatory diabetes (SOID), mild metabolic diabetes (MMD, reference), and mild age-related hypertension-predominant diabetes (MARD-H). Versus MMD, SOID showed higher risks of all-cause dementia (HR 1.24, 95% CI 1.01-1.52), vascular dementia (HR 1.42, 95% CI 1.01-1.99), stroke (HR 1.38, 95% CI 1.14-1.68), ischemic stroke (HR 1.48, 95% CI 1.21-1.82), all-cause mortality (HR 1.59, 95% CI 1.45-1.74), and cardiovascular death (HR 1.88, 95% CI 1.59-2.23). MARD-H showed modest relative but highest absolute risks. SOID showed lower gray matter and greater white matter hyperintensity. T2D subtypes show distinct vascular and neurological risks. The obesity-inflammation subtype carries elevated risks of dementia, stroke, mortality, and adverse brain changes.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Han, S., Zhou, Y., Sturkenboom, M., Biessels, G. J., & Ahmadizar, F. (2026). Data-driven subtypes of type 2 diabetes and risk of dementia, stroke, and brain structural changes in the UK Biobank. Diabetes Research and Clinical Practice. https://doi.org/10.1016/j.diabres.2026.113311

Vancouver

Han S, Zhou Y, Sturkenboom M, Biessels GJ, Ahmadizar F. Data-driven subtypes of type 2 diabetes and risk of dementia, stroke, and brain structural changes in the UK Biobank. Diabetes Research and Clinical Practice. 2026. doi:10.1016/j.diabres.2026.113311. PMID: 42107717.

BibTeX

@article{han2026-42107717,
  author  = {Han, Si and Zhou, Yingying and Sturkenboom, Miriam and Biessels, Geert Jan and Ahmadizar, Fariba},
  title   = {{Data-driven subtypes of type 2 diabetes and risk of dementia, stroke, and brain structural changes in the UK Biobank}},
  journal = {Diabetes Research and Clinical Practice},
  year    = {2026},
  doi     = {10.1016/j.diabres.2026.113311},
  pmid    = {42107717},
  url     = {https://doi.org/10.1016/j.diabres.2026.113311}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This study identified three subtypes of type 2 diabetes, with the severe obesity-related inflammatory subtype showing higher risks of dementia, stroke, and adverse brain changes. It suggests that recognizing diabetes subtypes may help identify people at higher risk, but it does not show that treating subtypes differently prevents dementia.

Study details

How this study scored 43/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 3 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 4 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 43 of 100.43 of 100 points earned57 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Diabetes Research and Clinical Practice)
Journal's citation record 2 / 4 Diabetes Research and Clinical Practice: journal h-index 181 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.5 citations a year over 2 year(s) since 2026
Impact for its field and year 4 / 6 Cited 14.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Fariba Ahmadizar: h-index 26 (OpenAlex, whole career)
Institution's track record 1 / 3 University Medical Center Utrecht: institution h-index 1,076 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 42107717)
Free to read 2 / 2 Free to read
Total 43 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Long-term cohort studies from nearby years

Also tagged “incidence”

1,084 studies in the library carry the topic tag “incidence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Long-term cohort studies

See all studies in Long-term cohort studies →